• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bisphosphonate-induced osteopetrosis.

作者信息

Whyte Michael P, Wenkert Deborah, Clements Karen L, McAlister William H, Mumm Steven

机构信息

Center for Metabolic Bone Disease and Molecular Research, Shriners Hospitals for Children, St. Louis, MO 63131-3597, USA.

出版信息

N Engl J Med. 2003 Jul 31;349(5):457-63. doi: 10.1056/NEJMoa023110.

DOI:10.1056/NEJMoa023110
PMID:12890844
Abstract
摘要

相似文献

1
Bisphosphonate-induced osteopetrosis.双膦酸盐诱导的骨硬化症。
N Engl J Med. 2003 Jul 31;349(5):457-63. doi: 10.1056/NEJMoa023110.
2
Bisphosphonates in children with bone diseases.患有骨病儿童的双膦酸盐类药物
N Engl J Med. 2003 Nov 20;349(21):2068-71; author reply 2068-71.
3
Do bisphosphonates make children's bones better or brittle?双膦酸盐会让儿童骨骼更强健还是更脆弱？
N Engl J Med. 2003 Jul 31;349(5):423-6. doi: 10.1056/NEJMp038103.
4
Bisphosphonates in children with bone diseases.
N Engl J Med. 2003 Nov 20;349(21):2068-71; author reply 2068-71.
5
IMAGES IN CLINICAL MEDICINE. Osteopetrosis and Erlenmeyer-Flask Deformity.临床医学影像。骨质石化症与烧瓶样畸形。
N Engl J Med. 2015 Sep 3;373(10):e12. doi: 10.1056/NEJMicm1407743.
6
Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.静脉注射帕米膦酸二钠与钙剂对糖皮质激素性骨质疏松的一级预防：一项前瞻性对照1年研究，比较单次输注、每3个月输注一次以及单纯使用钙剂的效果。
J Bone Miner Res. 2001 Jan;16(1):104-12. doi: 10.1359/jbmr.2001.16.1.104.
7
Congenital osteopetrosis: an unusual cause of hydrocephalus.先天性骨硬化症：脑积水的一种罕见病因。
Can Med Assoc J. 1968 Feb 17;98(7):362-5.
8
Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases.双膦酸盐诱导的骨硬化症：药物暴露停止后出现新的骨塑形缺陷、干骺端骨质减少和骨硬化性骨折。
J Bone Miner Res. 2008 Oct;23(10):1698-707. doi: 10.1359/jbmr.080511.
9
Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy.用强化双膦酸盐疗法治疗特发性高磷酸酶血症。
J Bone Miner Res. 2004 May;19(5):703-11. doi: 10.1359/JBMR.040127. Epub 2004 Jan 19.
10
Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment.二膦酸盐治疗后下颌骨骨转换相关细胞信号分析中 Msx-1 被抑制。
Oral Dis. 2011 May;17(4):433-42. doi: 10.1111/j.1601-0825.2010.01778.x. Epub 2011 Mar 2.

引用本文的文献

1
Osteogenesis imperfecta: pathogenesis, classification, and treatment.成骨不全症：发病机制、分类及治疗
Clin Pediatr Endocrinol. 2025 Jul;34(3):152-161. doi: 10.1297/cpe.2025-0009. Epub 2025 Mar 31.
2
Adoptive Transfer of Lepr Bone Marrow Cells Attenuates the Osteopetrotic Phenotype of / Mice.过继转移Lepr骨髓细胞可减轻/小鼠的骨硬化表型。
Int J Mol Sci. 2025 May 27;26(11):5120. doi: 10.3390/ijms26115120.
3
Trabecular bone scores in children with osteogenesis imperfecta respond differently to bisphosphonate treatment depending on disease severity.
成骨不全症患儿的小梁骨评分对双膦酸盐治疗的反应因疾病严重程度而异。
Front Pediatr. 2024 Dec 3;12:1500023. doi: 10.3389/fped.2024.1500023. eCollection 2024.
4
Medical Management for Fracture Prevention in Children with Osteogenesis Imperfecta.儿童成骨不全症骨折预防的医学管理。
Calcif Tissue Int. 2024 Dec;115(6):812-827. doi: 10.1007/s00223-024-01202-7. Epub 2024 Mar 29.
5
A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence.儿童和青少年骨质疏松症诊断与管理实用指南
Front Endocrinol (Lausanne). 2024 Jan 25;14:1266986. doi: 10.3389/fendo.2023.1266986. eCollection 2023.
6
Management of insufficiency fractures associated with long-term bisphosphonate therapy in a cat.猫长期双膦酸盐治疗相关不全骨折的管理
JFMS Open Rep. 2023 Aug 12;9(2):20551169231183752. doi: 10.1177/20551169231183752. eCollection 2023 Jul-Dec.
7
Denosumab use in osteogenesis imperfecta: an update on therapeutic approaches.地诺单抗在成骨不全症中的应用：治疗方法的最新进展
Ann Pediatr Endocrinol Metab. 2023 Jun;28(2):98-106. doi: 10.6065/apem.2346058.029. Epub 2023 Jun 30.
8
Brain-Type Creatine Kinase Release from Cultured Osteoclasts Exposed to Neridronate in Children Affected by Osteogenesis Imperfecta Type 1.在患有Ⅰ型成骨不全症的儿童中，暴露于奈立膦酸的培养破骨细胞释放脑型肌酸激酶的情况。
Biomedicines. 2023 Feb 4;11(2):458. doi: 10.3390/biomedicines11020458.
9
Quercetin potentiates the anti-osteoporotic effects of alendronate through modulation of autophagy and apoptosis mechanisms in ovariectomy-induced bone loss rat model.槲皮素通过调节自噬和凋亡机制增强阿仑膦酸钠在去卵巢诱导的骨丢失大鼠模型中的抗骨质疏松作用。
Mol Biol Rep. 2023 Apr;50(4):3693-3703. doi: 10.1007/s11033-023-08311-w. Epub 2023 Feb 24.
10
Alendronate treatment in cats with persistent ionized hypercalcemia: A retrospective cohort study of 20 cases.应用阿仑膦酸钠治疗持续性离子型高钙血症的猫：20 例回顾性队列研究。
J Vet Intern Med. 2022 Nov;36(6):1921-1930. doi: 10.1111/jvim.16508. Epub 2022 Oct 1.